technology
Measles Cases Rising in the US, Biotech Firms Begin Developing New Treatments
As measles infections increase across the United States, biotechnology companies are beginning work on new treatment options, with a focus on protecting the most vulnerable patients.
Why We Ran This
This story restores context often missing from outbreak coverage: not everyone can be vaccinated, and treatment research is how the medical community serves those the headlines overlook.
Approved by an editor